AIM logo
Subscribe

Deepcell Achieves Key Commercial Milestones: Revolutionizing Life Sciences with AI

Deepcell marks a new era in life sciences with its AI-powered REM-I platform, revolutionizing single cell analysis and research.
In a significant leap forward for artificial intelligence (AI) in life sciences, Deepcell, a leading company in AI-powered single cell analysis, has announced the achievement of crucial commercial milestones for its REM-I platform. This development marks a pivotal moment for the company, as it prepares to share its vision for the future of generative AI in single cell analysis at the upcoming 42nd annual J.P. Morgan Healthcare Conference. A Year of Remarkable Progress Deepcell's journey over the past year has been nothing short of extraordinary. According to Maddison Masaeli, Ph.D., Cofounder and CEO of Deepcell, "We launched the REM-I platform, completed technology evaluations across seven sites, launched the Spark program, and began operationalizing manufacturing. We've also placed
Subscribe or log in to Continue Reading

Uncompromising innovation. Timeless influence. Your support powers the future of independent tech journalism.

Subscribe

Already have an account? Sign In.

📣 Want to advertise in AIM Media House? Book here >

Picture of 理想
理想
AIM is the world's leading media and analyst firm dedicated to advancements and innovations in Artificial Intelligence. Reach out to us at info@aimmediahouse.com
25 July 2025 | 583 Park Avenue, New York
MachineCon 2025
The Biggest Exclusive Gathering of CDOs & AI Leaders In United States
View Event >>
Most Popular
From Enterprise AI
From AI Startups
From Leadership

Subscribe to our Newsletter: AIM Research’s most stimulating intellectual contributions on matters molding the future of AI and Data.

Boston CDO Vision-Popup